1. Hollowell JG, Staehling NW, Flanders WD et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87 (2): 489–99. 
2. Leese GP, Flynn RV, Jung RT et al. Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS). Clin Endocrinol 2008; 68 (2): 311–16.
3. Tunbridge WM, Evered DC, Hall R et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 1977; 7 (6): 481–93.
4. Vanderpump MP, Tunbridge WM, French JM et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43 (1): 55–68. 
5. Chakera AJ, Pearce SH, Vaidya B. Treatment for primary hypothyroidism: current approaches and future possibilities. Drug Des Devel Ther 2012; 6: 1–11.
6. Garber JR, Cobin RH, Gharib H et al. Clinical Practice Guidelines for Hypothyroidism in Adults: Co-sponsored by American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 2012; 11: 1–207.
7. Stagnaro-Green A, Abalovich M, Alexander E et al. Guidelines of the American thyroid association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011; 21 (10):1081–125.
8. Surks MI, Boucai L. Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab 2010; 95 (2): 496–502.
9. Lindholm J, Laurberg P. Hypothyroidism and thyroid substitution: historical aspects. J Thyroid Res 2011; 2011: 809341.
10. Bolk N, Visser TJ, Nijman J et al. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med 2010; 170 (22): 1996–2003.
11. Rajput R, Chatterjee S, Rajput M. Can levothyroxine be taken as evening dose? Comparative evaluation of morning versus evening dose of levothyroxine in treatment of hypothyroidism. 
J Thyroid Res 2011; 2011: 505239.
12. Roos A, Linn-Rasker SP, van Domburg RT et al. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch Intern Med 2005; 165 (15): 1714–20.
13. Turner MR, Camacho X, Fischer HD et al. Levothyroxine dose and risk of fractures in older adults: nested case-control study. BMJ 2011; 342: d2238.
14. Vadiveloo T, Donnan PT, Cochrane L, Leese GP. The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab 2011; 96 (5): 1344–51.
15. Caraccio N, Ferrannini E, Monzani F. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab 2002; 87: 1533–8.
16. Iqbal A, Jorde R, Figenschau Y. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromso Study. J Intern Med 2006; 260: 53–61. 
17. Viswanath AK, Avenell A, Philip S et al. Is annual surveillance of all treated hypothyroid patients necessary? BMC Endocr Disord 2007; 7: 4.

Н.А.Петунина, Л.В.Трухина, Н.С.Мартиросян  

Кафедра эндокринологии ФППОВ ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава РФ